The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 4907-4913

  Davis, Susan R ^a   Hirschberg, Angelica Lindén ^b   Wagner, Leigh K ^c   Lodhi, Imran ^c   Von Schoultz, Bo ^b  

^a MONASH UNIVERSITY   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GESTAGEN; TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; BODY MASS; BREAST DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; TRANSDERMAL PATCH;

EID: 73249114076     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1523     Document Type: Article

References (34)

1. Verheus M, Peeters PH, van Noord PA, van der Schouw YT, Grobbee DE, van Gils CH 2007Norelationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res 9:R53
2. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS, Dunning A, Doody D, Ponder B, Luben RN, Day NE, Easton D 2006 Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:1502-1508
3. Warren R 2004 Hormones and mammographic breast density. Maturitas 49:67-78
4. McCormack VA, dos Santos Silva I 2006 Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169
5. Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J 2008 Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 15:67-73
6. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD 2005 Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808
7. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R 2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168-175
8. Hofling M, Hirschberg AL, Skoog L, Tani E, Hägerström T, von Schoultz B 2007 Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 14:183-190
9. Dimitrakakis C, Zhou J, Bondy CA 2002 Androgens and mammary growth and neoplasia. Fertil Steril 77:S26-S33
10. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA 2000 Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14:1725-1730
11. Somboonporn W, Davis SR 2004 Testosterone and the breast: therapeutic implications for women. Endocr Rev 25:374-388
12. Hofling M, Löfgren L, von Schoultz E, Carlström K, Söderqvist G 2008 Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women. Gynecol Endocrinol 24:405-410
13. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA 2006 Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 166:1483-1489
14. Jick SS, Hagberg KW, Kaye JA, Jick H 2009 Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol 113:74-80
15. Davis SR, Wolfe R, Farrugia H, Ferdinand A, Bell RJ 2009 The incidence of invasive breast cancer among women prescribed testosterone for low libido. J Sex Med 6:1850-1856
16. Dimitrakakis C, Jones R, Liu A, Bondy CA 2004 Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 11:531-535
17. Hofling M, LundströmE, Azavedo E, Svane G, Hirschberg AL, von Schoultz B 2007 Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. Climacteric 10:155-163
18. Southren AL, Gordon GG, Tochimoto S 1968 Further study of factors affecting the metabolic clearance rate of testosterone in man. J Clin Endocrinol Metab 28:1105-1112
19. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarage A, Studd J; APHRODITE Study Team 2008 Testosterone for low libido in menopausal women not taking estrogen therapy. N Engl J Med 359:2005-2017
20. Tamimi RM, Byrne C, Colditz GA, Hankinson SE 2007 Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178-1187
21. Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE 2006 Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst 98:110-115
22. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS 2005 Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst 97:1366-1376
23. Opatrny L, Dell'Aniello S, Assouline S, Suissa S 2008 Hormone replacement therapy use and variations in the risk of breast cancer. BJOG 115:169-175; discussion 175
24. Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B 2002 Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 186:717-722
25. Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R 2008 The effects of tibolone in older postmenopausal women. N Engl J Med 359:697-708
26. Valdivia I, Ortega D 2000 Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Invest 20:101-107
27. Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM 2008 Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG 115:773-779
28. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J 2000 Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917-921
29. Hofling M, MaL, Sahlin L, Haglund C, Nordling S, von Schoultz B, Cline JM 2009 Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys. Climacteric 12:72-79
30. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S 2002 The association of breast mitogens with mammographic densities. Br J Cancer 87:876-882
31. Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack T 2009 The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev 18:102-112
32. Caire-Juvera G, Arendell LA, Maskarinec G, Thomson CA, Chen Z 2008 Associations between mammographic density and body composition Hispanic and non-Hispanic white women by menopause status. Menopause 15:319-325
33. Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M, Quesenberry C, Sternfeld B 2007 Mammographic density in a multiethnic cohort. Menopause 14:891-899
34. Torres-Mejía G, De Stavola B, Allen DS, Pérez- Gavilán JJ, Ferreira JM, Fentiman IS, Dos Santos Silva I 2005 Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 14:1052-1059